Home›Companies›1upHealth

1upHealth, Inc.

Updated Oct 27, 2026·Latest SEC filing Apr 18, 2023·Suggest an edit

About 1upHealth

1upHealth is a private company based in Boston, Massachusetts. It has reported $79,572,002 raised in four offerings on Form D since December 2018. Its chief executive is Joseph Gagnon.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 3, 2023Apr 18, 2023$45,000,002fully sold9$5.0MEquityRule 506(b)Form D ↗
Apr 1, 2021Apr 15, 2021$25,000,000fully sold7$3.5MEquityRule 506(b)Form D ↗
Jan 22, 2020Feb 5, 2020$8,000,000fully sold5$1.6MEquityRule 506(b)Form D ↗
Dec 17, 2018Dec 28, 2018$1,572,000of $2.3M target2$786KEquityRule 506(b)Form D ↗
Total, four offerings$79,572,002

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on 1upHealth's Form D filed Apr 18, 2023.

EK
Eden Avraham-Katz
Executive officer
LM
Lee Mooney
Director
DJ
David Jegen
Director
Also a director at Notabene.
Joseph Gagnon
Joseph Gagnon
President & CEO, director
Also a co-founder & CEO, director at Raynmaker.
JL
John Lambrecht
Executive officer
TJ
T. Law, Jr.
Director
RS
Ritwik Sahu
Director

Earlier filings also listed David Jegan (director, last listed Apr 2021) and Doug Williams (director, last listed Feb 2020).

Sources

  1. SEC1upHealth, Inc. filing history